Dylan Morris is a Managing Director at Insight Partners where he invests in Seed, Series A, Series B, Series C, and venture rounds across life sciences and bio-focused sectors, including technology-enabled approaches to drug discovery and development, new therapeutic modalities, curative therapies, bioengineering, and data science. He serves on the boards of Exsilio Therapeutics, Superluminal Medicines Inc., ImmuneBridge, Profluent Bio, and Unlearn.AI, and has invested in companies like Profluent Bio, Unlearn.AI, Superluminal Medicines, Kyverna Therapeutics, and Dyno Therapeutics. Dylan attended Harvard University and lives in the San Francisco Bay Area.
Dylan Morris, Managing Director @ Insight. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Dylan Morris from Insight Partners. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Dylan
Map your path to Dylan instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Dylan
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.